DeltaNp63 Is a Protective Marker of Progression in HGT1 Bladder Cancer

被引：0
|
作者：
Castillo-Martin, M.
Sopena, J. M. Gaya
Gladoun, N.
Karni-Schmidt, O.
Gonzalez, C.
Algaba, F.
Redorta, J. Palou
Cordon-Cardo, C.
机构：
[1] Mt Sinai Med Ctr, Mt Sinai Sch Med, New York, NY 10029 USA
[2] Fundacio Puigvert, Barcelona, Spain
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
823
引用
收藏
页码：199A / 200A
页数：2
相关论文
共 50 条
  • [21] Distinct Expression Profiles of p63 Isoforms during Bladder Cancer Progression
    Castillo-Martin, M.
    Karni-Schmidt, O.
    Gladoun, N.
    Domingo-Domenech, J.
    Cordon-Cardo, C.
    MODERN PATHOLOGY, 2011, 24 : 183A - 183A
  • [22] Distinct Expression Profiles of p63 Isoforms during Bladder Cancer Progression
    Castillo-Martin, A.
    Karni-Schmidt, O.
    Gladoun, N.
    Domingo-Domenech, J.
    Cordon-Cardo, C.
    LABORATORY INVESTIGATION, 2011, 91 : 183A - 183A
  • [23] Loss of heterozygosity on chromosome 9 as a potential marker of recurrence and progression in bladder cancer
    Edwards, J
    Duncan, P
    Going, JJ
    Watters, AD
    Bartlett, JMS
    BRITISH JOURNAL OF CANCER, 2000, 83 : 76 - 76
  • [24] The Interplay between Oxidative Phosphorylation and Glycolysis as a Potential Marker of Bladder Cancer Progression
    Petrella, Greta
    Ciufolini, Giorgia
    Vago, Riccardo
    Cicero, Daniel Oscar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 13
  • [25] Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survival
    Zhou, Jian
    Li, Jie
    Wang, Zengjun
    Yin, Changjun
    Zhang, Wei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (03) : E42 - E48
  • [26] GSTT1: A Marker of the Aggressiveness of Bladder Cancer
    Ha, Yun-Sok
    Yan, Chunri
    Park, Cheol
    Yun, Seok-Joong
    Moon, Sung-Kwon
    Choi, Yung Hyun
    Kim, Wun-Jae
    UROLOGIA INTERNATIONALIS, 2011, 86 (01) : 41 - 46
  • [27] α1-acid glycoprotein is marker of cancer progression
    Mikhailov, A.
    FEBS JOURNAL, 2006, 273 : 254 - 255
  • [28] TP53 gene mutations as an independent marker for urinary bladder cancer progression
    Ecke, T. H.
    Sachs, M. D.
    Lenk, S. V.
    Miller, K.
    Schlechte, H. H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 : 44 - 44
  • [29] TP53 gene mutations as an independent marker for urinary bladder cancer progression
    Ecke, Thorsten H.
    Sachs, Markus D.
    Lenk, Severin V.
    Loening, Stefan A.
    Schlechte, Horst H.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2008, 21 (05) : 655 - 661
  • [30] Neutrophil gelatinase-associated lipocalin (NGAL) as potential marker of bladder cancer progression
    Candido, Saverio
    Salemi, Rosella
    Pezzino, Franca Maria
    Talamini, Renato
    Polesel, Jerry
    McCubrey, James
    Travali, Salvatore
    Libra, Massimo
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S68 - S68
12345